Guangxi Liuzhou Pharm Co Ltd (603368) — Capital Reinvestment Ratio
Guangxi Liuzhou Pharm Co Ltd (603368) has a Capital Reinvestment Ratio of 0.81x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.64 Million) in capital expenditures (CN¥36.80 Million). See Guangxi Liuzhou Pharm Co Ltd (603368) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangxi Liuzhou Pharm Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Guangxi Liuzhou Pharm Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see Guangxi Liuzhou Pharm Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥838.51 Million | CN¥147.87 Million | ▼ -39.4% |
| 2023 | 0.29x | CN¥594.41 Million | CN¥172.94 Million | ▼ -19.6% |
| 2022 | 0.36x | CN¥506.43 Million | CN¥183.28 Million | ▼ -54.4% |
| 2021 | 0.79x | CN¥332.88 Million | CN¥264.04 Million | ▲ +101.4% |
| 2020 | 0.39x | CN¥664.69 Million | CN¥261.81 Million | ▼ -34.8% |
| 2019 | 0.60x | CN¥412.91 Million | CN¥249.54 Million | ▼ -95.0% |
| 2018 | 12.18x | CN¥22.30 Million | CN¥271.61 Million | ▲ +936.7% |
| 2016 | 1.17x | CN¥108.39 Million | CN¥127.33 Million | ▼ -64.7% |
| 2013 | 3.33x | CN¥22.33 Million | CN¥74.31 Million | ▲ +1472.1% |
| 2012 | 0.21x | CN¥60.51 Million | CN¥12.81 Million | ▼ -23.2% |
| 2011 | 0.28x | CN¥133.38 Million | CN¥36.78 Million | — |